Drug Type Small molecule drug |
Synonyms Efonidipine, Efonidipine hydrochloride, Efonidipine hydrochloride ethanol + [9] |
Target |
Mechanism L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (16 Sep 1998), |
Regulation- |
Molecular FormulaC36H45ClN3O8P |
InChIKeyIKBJGZQVVVXCEQ-UHFFFAOYSA-N |
CAS Registry111011-76-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01604 | Efonidipine Hydrochloride Ethanolate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | KR | - | 21 Jun 2003 |
Angina Pectoris | JP | 16 Sep 1998 | |
Hypertension, Renal | JP | 16 Sep 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebrovascular Disorders | Phase 2 | JP | - | - |